This article is part of the supplement: The Scientific Basis of Rheumatology
Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics
-
* Corresponding author: Hideaki Nagase h.nagase@ic.ac.uk
Arthritis Res 2002, 4(Suppl 3):S51-S61 doi:10.1186/ar573
London, UK. 24-26 June 2002
Accesses
- Last 30 days: 61 accesses
- Last 365 days: 575 accesses
- All time: 8792 accesses
Cited by
BioMed Central: 2 citations
|
Review
Drugs in development: bisphosphonates and metalloproteinase inhibitors Jon B Catterall, Tim E Cawston Arthritis Res Ther 2003, 5:12-24 (8 November 2002) |
|
Review
Matrix metalloproteinases in arthritic disease Gillian Murphy, Vera Knäuper, Susan Atkinson, George Butler, William English, Mike Hutton, Jan Stracke, Ian Clark Arthritis Res 2002, 4(Suppl 3):S39-S49 (9 May 2002) |